SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-22-006758
Filing Date
2022-05-13
Accepted
2022-05-13 16:15:58
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q zivo_10q.htm   iXBRL 10-Q 865711
2 CERTIFICATION zivo_ex311.htm EX-31.1 8334
3 CERTIFICATION zivo_ex312.htm EX-31.2 8344
4 CERTIFICATION zivo_ex321.htm EX-32.1 3083
5 CERTIFICATION zivo_ex322.htm EX-32.2 3115
  Complete submission text file 0001654954-22-006758.txt   4970374

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA zivo-20220331.xsd EX-101.SCH 59408
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE zivo-20220331_lab.xml EX-101.LAB 294626
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zivo-20220331_cal.xml EX-101.CAL 40050
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zivo-20220331_pre.xml EX-101.PRE 245151
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zivo-20220331_def.xml EX-101.DEF 140634
56 EXTRACTED XBRL INSTANCE DOCUMENT zivo_10q_htm.xml XML 935650
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Filer) CIK: 0001101026 (see all company filings)

IRS No.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40449 | Film No.: 22922911
SIC: 2836 Biological Products, (No Diagnostic Substances)